Objectives To examine the relationship between periprocedural bleeding complications and
major adverse cardiovascular events (MACEs) and mortality outcomes following …

Aims We sought to investigate the prognostic impact of co-morbid burden as defined by the
Charlson Co-morbidity Index (CCI) in patients with a range of prevalent cardiovascular …

Background Patients at high risk for bleeding who undergo percutaneous coronary
intervention (PCI) often receive bare-metal stents followed by 1 month of dual antiplatelet …

Background Everolimus-eluting stent (EES) reduces the risk of restenosis in elective
percutaneous coronary intervention. However, the use of drug-eluting stent in patients with …

Diabetic mellitus (DM) patients with coronary artery disease (CAD) are at higher risk of
cardiovascular events compared with non-DM individuals. While aggressive cardiovascular …

Objectives: This study sought to assess the 2-year outcomes of the population included in
the EXAMINATION (Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment …

Background Adherence to dual antiplatelet therapy (DAPT) is critical after coronary stenting.
Although adherence rates are frequently assessed in clinical trials, adherence rates in the …

Percutaneous coronary intervention (PCI) is considered a relatively safe procedure
associated with low rates of complications, but is inevitably associated with short and mid-to …

BACKGROUND AND RATIONALE: Major bleeding is a powerful predictor of morbidity and
mortality after percutaneous coronary intervention (PCI). To avoid prolonged dual …

Background Bleeding risk scores have shown a limited predictive ability in elderly patients
with acute coronary syndromes (ACS). No study explored the role of a comprehensive …